<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03532386</url>
  </required_header>
  <id_info>
    <org_study_id>Ayman Shehata</org_study_id>
    <secondary_id>Salah A Naglah</secondary_id>
    <nct_id>NCT03532386</nct_id>
  </id_info>
  <brief_title>Outcomes of Intra-Cytoplasmic Sperm Injection in Infertile Men With Non-tense Vaginal Hydrocele</brief_title>
  <official_title>Outcomes of Intra-Cytoplasmic Sperm Injection in Infertile Men With Non-tense Vaginal Hydrocele</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infertile men due to oligoasthenospermia with non-tense hydroceles are subjected to ICSI&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty male infertile patients with Oligoasthenospermia were recruited from outpatient clinic&#xD;
      of Urology Department, Tanta University. Patients were selected according to inclusion and&#xD;
      exclusion criteria. The inclusion criteria were: (a) infertile couples due to male factor (b)&#xD;
      Oligoasthenospermia (c) Normal hormonal profile (serum free and total testosterone,&#xD;
      prolactin, Estrogen and LH), (d) presence or absence of non-tense vaginal hydrocel. The&#xD;
      exclusion criteria were: (a) Presence of varicocele, (b) History of recent testicular trauma,&#xD;
      (c) History of recent or old testicular inflammation, (d) Tense vaginal hydrocele and (e)&#xD;
      presence of potential female pathologies.&#xD;
&#xD;
      Sample size calculation: With H0 denoting higher success rates for ICSI in absence of&#xD;
      non-tense hydrocele and confidence level of 95% and interval of 5 the sample size was 30. The&#xD;
      program used was Epi info 0.7.&#xD;
&#xD;
      Randomization and allocation: Enrolled patients were randomly allocated into 2 groups. The&#xD;
      first group (n=30) who have oligoasthenospermia with non-tense vaginal hydrocele (Study&#xD;
      group) and the second group (n=30) who have oligoasthenospermia with no hydrocele group&#xD;
      (Control group). Randomization was done by computer-generated serial numbers where each&#xD;
      number was enveloped. Each number denotes a certain allocation group. Allocation was by&#xD;
      alternate method and envelope opening did not change allocation.&#xD;
&#xD;
      Methods: Males were assessed by genital examination, ultrasound and scrotal Doppler. Female&#xD;
      partners were given long agonist stimulation protocols, Ovum pickup fertilization by sperms&#xD;
      and then embryo transfer on day 5. Demographic data of both couples, duration of infertility,&#xD;
      seminal parameters (WHO-2010) and results of ICSI in these couples were recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>2 weeks after ICSI</time_frame>
    <description>Success of ICSI with positive pregnancy test in serum</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Infertility, Male</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Infertile men with oligoasthenospermia with non-tense vaginal hydrocele subjected to ICSI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>infertile men with oligoasthenospermia without hydrocele subjected to ICSI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICSI</intervention_name>
    <description>ICSI for both couples</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All infertile couples with male factor (oligoasthenospermia) due to non-tense hydrocele&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infertile couples due to male factor&#xD;
&#xD;
          -  Oligoasthenospermia&#xD;
&#xD;
          -  Normal hormonal profile (serum free and total testosterone, prolactin, Estrogen and&#xD;
             LH)&#xD;
&#xD;
          -  Presence or absence of non-tense vaginal hydrocele&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of varicocele&#xD;
&#xD;
          -  History of recent testicular trauma&#xD;
&#xD;
          -  History of recent or old testicular inflammation&#xD;
&#xD;
          -  Tense vaginal hydrocele&#xD;
&#xD;
          -  Presence of potential female pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ayman Shehata Dawood</name>
      <address>
        <city>Tanta</city>
        <state>Algharbia</state>
        <zip>31111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>December 9, 2018</last_update_submitted>
  <last_update_submitted_qc>December 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ayman S Dawood, MD</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>male factor infertility</keyword>
  <keyword>oligoasthenospermia</keyword>
  <keyword>vaginal hydrocele</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
    <mesh_term>Testicular Hydrocele</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not accepted to share patient data only results of study to be published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

